Improvement of dialysis headache after treatment with ACE-inhibitors but not angiotensin II receptor blocker: A case report with pathophysiological considerations

Cephalalgia

Volumn 25, Issue 1, 2005, Pages 71-74

  Leinisch Dahlke, E ^a   Schmidt Wilcke, T ^a   Kramer B K ^a   May, Arne ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIMIGRAINE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOSINOPRIL; LISINOPRIL; LOSARTAN; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANEMIA; ARTICLE; CASE REPORT; DIALYSIS; DIZZINESS; FEMALE; HEADACHE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; MICTURITION DISORDER; MIGRAINE WITHOUT AURA; NAUSEA; PATHOPHYSIOLOGY; PHOTOPHOBIA; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TACHYCARDIA; VOMITING;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEADACHE; HUMANS; RECEPTORS, ANGIOTENSIN; RENAL DIALYSIS;

EID: 12444273759     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00804.x     Document Type: Article

References (14)

1. Newman LC, Solomon SS. Infectious Toxic, and Metabolic Headache. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff's Headache and Other Head Pain, 7th edn. New York: Oxford University Press, 2001:434-46.
2. Headache Classification Committee of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl 7:1-96.
3. Antoniazzi AL, Bigal ME, Bordini CA, Speciali JG. Headache associated with dialysis: the International Headache Society criteria revisited. Cephalalgia 2003; 23:146-9.
4. Antoniazzi AL, Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Headache and hemodialysis: a prospective study. Headache 2003; 43:99-102.
5. Arieff IA. Dialysis disequlibrium syndrome, current concepts on pathogenesis and prevention. Kidney Int 1994; 45:629-35.
6. Bana DS, Yap AU, Graham JR. Headache during hemodialysis. Headache 1972; 12:1-14.
7. van Olden RW, van Acker BA, Koomen GC, Krediet RT, Arisz L. Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 1995; 10:2274-80.
8. Gehr TW, Sica DA, Grasela DM, Duchin KL. The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients. Eur J Clin Pharmacol 1993; 45:431-6.
9. Shionoiri H, Naruse M, Minamisawa K, Ueda S, Himeno H, Hiroto S, et al. Clinical pharmacokinetics and clinical potential. Clin Pharmacokinet 1997; 32:460-80.
10. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. Bmj 2001; 322:19-22.
11. Wright JW, Reichert JR, Davis CJ, Harding JW. Neural plasticity and the brain renin-angiotensin system. Neurosci Biobehav Rev 2002; 26:529-52.
12. Jackson EK, Garrison JC. Renin and Angiontensin. In: Hardman Lel JG, Molinoff PB, Ruddon RW, Goodman Gilman A, editors. The Pharmacological Basis of Therapeutics, 9th edn, New York: McGraw-Hill 1996: 733-58.
13. Ranadive SA, Chen AX, Serajuddin AT. Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors. Pharm Res 1992; 9:1480-6.
14. Sakaguchi K, Chai SY, Jackson B, Johnston CI, Mendelsohn FA. Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography. Clin Exp Pharmacol Physiol 1987; 14:155-8.